Inventor
VARADI KATALIN
AT20 patents
⚠️ This page may combine multiple inventors who share the name “VARADI KATALIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAXTER INT
4 patentsUS8623612B2Jan 7, 2014
Method for testing treatment of ADAMTS13 deficiency
BAXTER INT10 citations92
US7683158B2Mar 23, 2010
Pegylated factor VIII
BAXTER INT16 citations92
US9110085B2Aug 18, 2015
Methods of testing effectiveness of a treatment for thromobotic thrombocytopenic purpura by measuring ADAMTS13-mediated in vivo cleavage of von Willebrand factor
BAXTER INT8 citations83
US8053561B2Nov 8, 2011
Pegylated factor VIII
BAXTER INT0 citations51
BAXALTA INC
3 patentsUS10209263B2Feb 19, 2019
Methods of measuring adamts 13 activity
BAXALTA INC5 citations83
US9488651B2Nov 8, 2016
Methods of measuring ADAMTS 13 activity
BAXALTA INC3 citations83
US9547016B2Jan 17, 2017
Method and compositions for specifically detecting physiologically acceptable polymer molecules
BAXALTA INC1 citations50
VARADI KATALIN
3 patentsUS8415114B2Apr 9, 2013
Methods of measuring ADAMTS13-mediated in vivo cleavage of von Willebrand factor and uses thereof
VARADI KATALIN8 citations81
US9274122B2Mar 1, 2016
Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation)
VARADI KATALIN0 citations48
US8735086B2May 27, 2014
Kit for measuring the thrombin generation in a sample of a patient's blood or plasma
VARADI KATALIN0 citations42
IMMUNO AG
3 patentsUS5804181ASep 8, 1998
Pharmaceutical preparation for the prevention and treatment of blood coagulation disorders
IMMUNO AG7 citations74
US5643739AJul 1, 1997
Assay for determining sensitivity to activated protein C
IMMUNO AG12 citations72
US5863896AJan 26, 1999
Evaluation of substances for altering and for increasing APC response
IMMUNO AG3 citations54